Biote price target lowered to $2.50 from $3 at TD Cowen

TD Cowen lowered the firm’s price target on Biote (BTMD) to $2.50 from $3 and keeps a Buy rating on the shares. The firm said 4Q25 sales and& EBITDA beat but FY26 guide was below Street, reflecting the impact of voluntary recall, a step up in investment, and growth resuming in 2H26.